Streetbeat News

Revenues

NVEE

NV5 projects its FY24 revenue to be between $937M-$942M, surpassing the $931M estimate. Additionally, the company forecasts its adjusted EPS to be in the range of $5.05-$5.11, slightly above the $5.01 estimate.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:40 pm

RDVT

Red Violet reported a Q1 adjusted earnings increase to $0.22 per share from $0.16 YoY, with sales rising to $17.51M from $14.63M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:40 pm

ACEL

Accel Entertainment reported Q1 sales of $301.800 million, surpassing the analyst consensus estimate of $295.743 million by 2.05% and marking a 2.93% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:40 pm

LVLU

Lulu's Fashion Lounge has revised its FY24 net revenue outlook from $350M-$370M to $350M-$360M, slightly below the estimated $354.58M, due to softer than expected net revenue in Q1 2024. However, the company is optimistic about improving its gross margin and maintaining cost discipline, leading to an increased low end of its Adjusted EBITDA outlook for the year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:39 pm

LAB

Standard BioTools has reaffirmed its revenue guidance for fiscal year 2024, expecting it to be in the range of $200 million to $205 million.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:39 pm

ASM

Avino Silver & Gold Mines (AMEX:ASM) reported Q1 2024 earnings of $0.02 per share, meeting analyst estimates, and a 100% increase from the previous year. However, their sales of $12.393M fell short of the $13.666M estimate, a 9.32% miss, but still represented a 26.14% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:39 pm

BNGO

Bionano Genomics has reaffirmed its revenue guidance for fiscal year 2024, projecting revenues to be in the range of $37 million to $41 million. This announcement underscores the company's confidence in its financial outlook and operational performance.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:39 pm

MRVI

Maravai LifeSciences has reaffirmed its revenue guidance for 2024, projecting revenues to be in the range of $265 million to $285 million. This announcement is a significant indicator of the company's financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:38 pm

PYCR

Paycor HCM forecasts its FY24 revenue to be between $650M and $652M, slightly below the estimated $653.898M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:36 pm

PYCR

Paycor HCM forecasts its Q4 2024 revenue to be between $160M-$162M, which is below the estimated $164.152M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:35 pm